DK0661541T3 - Fremgangsmåde til fremstilling af langtidsstabile klare sera - Google Patents

Fremgangsmåde til fremstilling af langtidsstabile klare sera

Info

Publication number
DK0661541T3
DK0661541T3 DK94120089T DK94120089T DK0661541T3 DK 0661541 T3 DK0661541 T3 DK 0661541T3 DK 94120089 T DK94120089 T DK 94120089T DK 94120089 T DK94120089 T DK 94120089T DK 0661541 T3 DK0661541 T3 DK 0661541T3
Authority
DK
Denmark
Prior art keywords
term stable
producing long
stable clear
sera
clear sera
Prior art date
Application number
DK94120089T
Other languages
Danish (da)
English (en)
Inventor
Hans Dr Vermeer
Tibor Dr Toth
Gerhard Dr Muenscher
Original Assignee
Dade Behring Marburg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dade Behring Marburg Gmbh filed Critical Dade Behring Marburg Gmbh
Application granted granted Critical
Publication of DK0661541T3 publication Critical patent/DK0661541T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacture, Treatment Of Glass Fibers (AREA)
  • Treatment Of Steel In Its Molten State (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Soil Conditioners And Soil-Stabilizing Materials (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94120089T 1993-12-29 1994-12-19 Fremgangsmåde til fremstilling af langtidsstabile klare sera DK0661541T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4344868A DE4344868A1 (de) 1993-12-29 1993-12-29 Verfahren zur Herstellung langzeitstabiler klarer Seren

Publications (1)

Publication Number Publication Date
DK0661541T3 true DK0661541T3 (da) 2000-04-25

Family

ID=6506473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94120089T DK0661541T3 (da) 1993-12-29 1994-12-19 Fremgangsmåde til fremstilling af langtidsstabile klare sera

Country Status (9)

Country Link
US (1) US5714333A (ja)
EP (1) EP0661541B1 (ja)
JP (1) JP3365693B2 (ja)
AT (1) ATE187252T1 (ja)
AU (1) AU700355B2 (ja)
CA (1) CA2138594C (ja)
DE (2) DE4344868A1 (ja)
DK (1) DK0661541T3 (ja)
ES (1) ES2141190T3 (ja)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829531A1 (de) * 1978-07-05 1980-01-24 Heuck Claus Christian Dr Rer N Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben
DE3303083A1 (de) * 1983-01-31 1984-08-02 Behringwerke Ag, 3550 Marburg Immunologisches latex-agglutinationsverfahren und mittel
JPS6234059A (ja) * 1985-08-07 1987-02-14 Sankyo Co Ltd 固相化試薬の安定化剤
DE3719196A1 (de) * 1987-06-09 1988-12-29 Behringwerke Ag Verwendung von polyinylpyrrolidon (pvp) zur truebungsminderung von seren, kontrollseren enthaltend pvp und verfahren zu deren herstellung
DE4202923A1 (de) * 1992-02-01 1993-08-05 Behringwerke Ag Verfahren zur bestimmung von antigenen oder antikoerpern in gegenwart eines immunkomplexes
TW593567B (en) * 2000-07-31 2004-06-21 Ciba Sc Holding Ag Dispersant compositions improving the heat stability of transparent pigments
EP1372211A3 (en) * 2002-06-12 2004-01-07 Matsushita Electric Industrial Co., Ltd. Dielectric filter, communication apparatus, and method of controlling resonance frequency

Also Published As

Publication number Publication date
CA2138594C (en) 2008-11-18
DE59408965D1 (de) 2000-01-05
CA2138594A1 (en) 1995-06-30
EP0661541A3 (de) 1996-01-31
AU8177494A (en) 1995-07-06
EP0661541B1 (de) 1999-12-01
EP0661541A2 (de) 1995-07-05
JPH07209298A (ja) 1995-08-11
AU700355B2 (en) 1999-01-07
JP3365693B2 (ja) 2003-01-14
ES2141190T3 (es) 2000-03-16
US5714333A (en) 1998-02-03
DE4344868A1 (de) 1995-08-03
ATE187252T1 (de) 1999-12-15

Similar Documents

Publication Publication Date Title
DK0629608T3 (da) Fremgangsmåde til fremstilling af N-acyl-N,N',N'-ethylendiamintrieddikesyrederivater
DK318088A (da) Vaeskeformig, vandig detergentsammensaetning og fremgangsmaade til fremstilling af samme
DK284988D0 (da) Fremgangsmaade til fremstilling af den 2,2-paracyclophandimer, der anvendes til fremstilling af paylen
DE69106594D1 (de) Herstellung von Zitronensäure.
DK0557199T3 (da) Polyethylenglycol-hirudin-konjugater, fremgangsmåde til fremstilling deraf og anvendelse deraf til behandling af tromboser
DK0422566T3 (da) Fremgangsmåde til fremstilling af 3-(L-pyroglutamyl)-L-thiazolidin-4-carboxylsyre og derivater deraf
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
DE58905079D1 (de) Neue alpha-aminocarbonsaeure-derivate, ihre herstellung und verwendung.
DK0407961T3 (da) Fremgangsmåde til fremstilling af 1,1,1-trifluor-2-chlorethan
DE68912809D1 (de) Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin.
DE59200298D1 (de) Verfahren zur Herstellung von 2,4-Dichlorfluorbenzol.
DK0661541T3 (da) Fremgangsmåde til fremstilling af langtidsstabile klare sera
DK379387D0 (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
DE59106607D1 (de) Verfahren zur Herstellung von 2,2-disubstituierten Pentan-1,5-diaminen.
DE59103040D1 (de) Verfahren zur Herstellung von symmetrischen 2,2'-Methylen-bis-benztriazolylphenolen.
DK0488345T3 (da) Optisk aktive 1,4-dihydropyridinderivater og fremgangsmåder til fremstilling deraf
DE69107897D1 (de) Verfahren zur Herstellung von N,N'-bis(tetrabromophthalimid).
DE3888543D1 (de) Zusammensetzungen zur herstellung von gasdurchlässigen kontaktlinsen.
DK364088D0 (da) Fremgangsmaade til fremstilling af flade emner, saasom luvforsynede maatter
DE69002496D1 (de) Herstellung von fluorphenolen.
DE59203827D1 (de) Verfahren zur Herstellung von 2,2-Bis-hydroxymethyl-butandiol-(1,4).
DK0730861T3 (da) Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
DE59006801D1 (de) Herstellung von Imidomethylphthalocyanin-Derivaten.
DK0377437T3 (da) Fremgangsmåde til fremstilling af 2,4-diamino-6-piperidinylpyrimidin-3-N-oxid
ATE104986T1 (de) Aminsalze von 1,4,2-oxazaphospholidin-2-alkoxy-2oxid-4-essigs|uren.